Source:http://linkedlifedata.com/resource/pubmed/id/17393517
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2007-4-3
|
pubmed:abstractText |
Cytokines such as tumor necrosis factor alpha (TNF-alpha) are key factors in liver inflammation. Supplementation with essential omega-3 polyunsaturated fatty acids (n-3 PUFA) has been demonstrated to lower TNF-alpha and IL-1 production in mononuclear cells. An inflammation-dampening effect has been observed with increased omega-3 fatty acid supplementation in several inflammatory diseases. In this study, we used the transgenic fat-1 mouse, expressing a Caenorhabditis elegans desaturase endogenously forming n-3 PUFA from n-6 PUFA, to analyze the effect of an increased n-3 PUFA tissue status in the macrophage-dependent acute D-galactosamine/lipopolysaccaride (D-GalN/LPS) hepatitis model. We show less severe inflammatory liver injury in fat-1 mice with a balanced n-6/n-3 PUFA ratio as evidenced by reduced serum alanine aminotransferase levels and less severe histological liver damage. This decreased inflammatory response was associated with decreased plasma TNF-alpha levels and with reduced hepatic gene expression of TNF-alpha, IL-1beta, IFN-gamma and IL-6 in fat-1 mice, leading to a decreased rate of apoptosis in livers from fat-1 animals, as measured by DAPI-staining. CONCLUSION: The results of this study offer evidence for an inflammation dampening effect of omega-3 polyunsaturated fatty acids in the context of liver inflammation.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0270-9139
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
45
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
864-9
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:17393517-Alanine Transaminase,
pubmed-meshheading:17393517-Animals,
pubmed-meshheading:17393517-Cytokines,
pubmed-meshheading:17393517-Drug-Induced Liver Injury,
pubmed-meshheading:17393517-Fatty Acids, Omega-3,
pubmed-meshheading:17393517-Fatty Acids, Omega-6,
pubmed-meshheading:17393517-Liver,
pubmed-meshheading:17393517-Male,
pubmed-meshheading:17393517-Mice,
pubmed-meshheading:17393517-Mice, Inbred C57BL,
pubmed-meshheading:17393517-Mice, Transgenic
|
pubmed:year |
2007
|
pubmed:articleTitle |
Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines.
|
pubmed:affiliation |
Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|